会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • NOVEL SCAVENGER RECEPTOR
    • 新的SCAVENGER受体
    • US20100113749A1
    • 2010-05-06
    • US12579948
    • 2009-10-15
    • Nobutaka Wakamiya
    • Nobutaka Wakamiya
    • C07K16/18
    • C07K16/28A01K2217/05A61K38/00C07K14/705G01N2500/00G01N2800/00G01N2800/32
    • Novel scavenger receptors having an SR structure and a collectin-like structure are provided, which can be utilized in the elucidation of mechanisms of macrophage and basic immunity; in the elucidation of mechanisms of the development of a wide variety of diseases such as arteriosclerosis, diabetic complications and Alzheimer's disease, hyper β-lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo α-lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections; in the diagnostic, prophylactic and therapeutic methods thereof; and in the development of reagents and drugs for the same. The novel scavenger receptors include proteins comprising an amino acid sequence set out in SEQ ID NO: 2, 4 or 24 or proteins having equivalent properties to the same, or derivatives or fragments thereof as well as isolated polynucleotides comprising a nucleotide sequence encoding these proteins, and related molecules such as antibodies, antagonists and the like. Also disclosed are methods for the treatment using the same.
    • 提供具有SR结构和集合蛋白样结构的新型清道夫受体,其可用于阐明巨噬细胞和基本免疫的机制; 阐明各种疾病如动脉硬化,糖尿病并发症和阿尔茨海默氏病,高胆固醇血症,高胆固醇血症,高甘油三酯血症,低α脂蛋白血症,移植,粥样斑块切除术,血管生成后再狭窄,细菌感染等各种疾病的发展机制; 在其诊断,预防和治疗方法中; 并在开发试剂和药物方面相同。 新型清道夫受体包括包含SEQ ID NO:2,4或24所示的氨基酸序列的蛋白质或与其相同性质的蛋白质或其衍生物或片段,以及包含编码这些蛋白质的核苷酸序列的分离的多核苷酸, 和相关分子如抗体,拮抗剂等。 还公开了使用其处理的方法。
    • 4. 发明授权
    • Scavenger receptors
    • 清道夫受体
    • US07189809B2
    • 2007-03-13
    • US10203860
    • 2001-02-08
    • Nobutaka Wakamiya
    • Nobutaka Wakamiya
    • C01K14/705G07N33/53A61K39/00C12N15/06
    • C07K16/28A01K2217/05A61K38/00C07K14/705G01N2500/00G01N2800/00G01N2800/32
    • Novel scavenger receptors having an SR structure and a collectin-like structure are provided, which can be utilized in the elucidation of mechanisms of macrophage and basic immunity; in the elucidation of mechanisms of the development of a wide variety of diseases such as arteriosclerosis, diabetic complications and Alzheimer's disease, hyper β-lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo α-lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections; in the diagnostic, prophylactic and therapeutic methods thereof; and in the development of reagents and drugs for the same. The novel scavenger receptors include proteins comprising an amino acid sequence set out in SEQ ID NO: 2, 4 or 24 or proteins having equivalent properties to the same, or derivatives or fragments thereof as well as isolated polynucleotides comprising a nucleotide sequence encoding these proteins, and related molecules such as antibodies, antagonists and the like. Also disclosed are methods for the treatment using the same.
    • 提供具有SR结构和集合蛋白样结构的新型清道夫受体,其可用于阐明巨噬细胞和基本免疫的机制; 在阐明各种疾病如动脉硬化,糖尿病并发症和阿尔茨海默病,高β脂蛋白血症,高胆固醇血症,高甘油三酯血症,低α脂蛋白血症,移植,粥样斑块切除术,血管生成后再狭窄,细菌感染等各种疾病的发展机制之后; 在其诊断,预防和治疗方法中; 并在开发试剂和药物方面相同。 新型清道夫受体包括包含SEQ ID NO:2,4或24所示的氨基酸序列的蛋白质或与其相同性质的蛋白质或其衍生物或片段,以及包含编码这些蛋白质的核苷酸序列的分离的多核苷酸, 和相关分子如抗体,拮抗剂等。 还公开了使用其处理的方法。